PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
about
Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesisDissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration.Novel pathways and molecular targets for the treatment of sarcoma.Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.Melanoma biomolecules: independently identified but functionally intertwined.Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.
P2860
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@en
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@nl
type
label
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@en
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@nl
prefLabel
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@en
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@nl
P2093
P2860
P50
P1476
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
@en
P2093
Elizabeth Charytonowicz
Igor Matushansky
Josep Domingo Doménech
Mireia Castillo-Martín
P2860
P2888
P304
P356
10.1007/S12094-012-0784-4
P577
2012-03-01T00:00:00Z